Publikationen (105) Publikationen von Miguel Torralba González de Suso

2024

  1. A Phase III Randomized Controlled Trial of Plitidepsin, a Marine-Derived Compound, in Hospitalized Adults With Moderate COVID-19

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 79, Núm. 4, pp. 910-919

  2. Application of Machine Learning Techniques to Assess Alpha-Fetoprotein at Diagnosis of Hepatocellular Carcinoma

    International Journal of Molecular Sciences, Vol. 25, Núm. 4

  3. Assessment of Albumin-Incorporating Scores at Hepatocellular Carcinoma Diagnosis Using Machine Learning Techniques: An Evaluation of Prognostic Relevance

    Bioengineering, Vol. 11, Núm. 8

  4. Bictegravir/Emtricitabine/Tenofovir Alafenamide in a Multicentre Cohort: Real-Life Experience From Spain

    Annals of Pharmacotherapy, Vol. 58, Núm. 2, pp. 140-147

  5. Effectiveness and Safety of Direct-acting Antivirals for Treatment of Adolescents With HCV/HIV Coinfection: Real-world Data From Europe

    Pediatric Infectious Disease Journal, Vol. 43, Núm. 5, pp. E155-E159

  6. Eficacia de la práctica de yoga y del ejercicio aeróbico frente al standard of care en pacientes con fibromialgia. Estudio FIB-YOGA-EA-SOC

    Metas de enfermería, Vol. 27, Núm. 1, pp. 7-17

  7. Factors associated with Glycemia Risk Index in a cohort of patients with type 1 Diabetes Mellitus and Latent Autoimmune Diabetes In Adults (LADA)

    Endocrine, Vol. 86, Núm. 2, pp. 574-583

  8. HBsAg level defines different clinical phenotypes of HBeAg(−) chronic HBV infection related to HBV polymerase-specific CD8+ cell response quality

    Frontiers in Immunology, Vol. 15

  9. HIV-1 resistance and virological failure to treatment with the integrase inhibitors bictegravir, cabotegravir, and dolutegravir: a systematic literature review

    AIDS Reviews, Vol. 26, Núm. 2, pp. 67-79

  10. IL-15 boosts activated HBV core-specific CD8+ progenitor cells via metabolic rebalancing in persistent HBV infection

    iScience, Vol. 27, Núm. 1

  11. Leprosy in Spain: A Descriptive Study of Admissions at Fontilles Sanatorium between 1909 and 2020

    Tropical Medicine and Infectious Disease, Vol. 9, Núm. 6

  12. Machine Learning-Based Assessment of Survival and Risk Factors in Non-Alcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma for Optimized Patient Management

    Cancers, Vol. 16, Núm. 6

  13. Prognostic Factors for Mortality in Hepatocellular Carcinoma at Diagnosis: Development of a Predictive Model Using Artificial Intelligence

    Diagnostics, Vol. 14, Núm. 4

  14. Prognostic Impact of Metabolic Syndrome and Steatotic Liver Disease in Hepatocellular Carcinoma Using Machine Learning Techniques

    Metabolites, Vol. 14, Núm. 6

2023

  1. Cabotegravir and Rilpivirine Long-Acting Antiretroviral Therapy Administered Every 2 Months is Cost-Effective for the Treatment of HIV-1 in Spain

    Infectious Diseases and Therapy, Vol. 12, Núm. 8, pp. 2039-2055

  2. Changes in the epidemiology of hepatitis A: Clinical and preventive implications

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 2, pp. 116-123

  3. Correction: Impact of an enhanced screening program on the detection of non-AIDS neoplasias in patients with human immunodeficiency virus infection (Trials, (2021), 22, 1, (851), 10.1186/s13063-021-05777-6)

    Trials

  4. Effectiveness, durability and safety of dolutegravir and lamivudine versus bictegravir, emtricitabine and tenofovir alafenamide in a real-world cohort of HIVinfected adults

    PLoS ONE, Vol. 18, Núm. 9 September

  5. Neumonía por Pneumocystis

    Colección de casos clínicos cerrados de la Facultad de Medicina y Ciencias de la Salud - Universidad de Alcalá (2021-2022) (Servicio de Publicaciones), pp. 68-81

  6. Plitidepsin in adult patients with COVID-19 requiring hospital admission: A long-term follow-up analysis

    Frontiers in Cellular and Infection Microbiology, Vol. 13